Activity Title: 2017 Virtual Symposium (Non-CME): Ensuring Access to Evidence-Based Therapies in High Risk Special Populations: Statin Intolerance, Racial/Ethnic Minorities and Familial Hypercholesterolemia
Activity Format: Virtual Symposium
Program Description:
Despite advances in medical therapies and new treatment modalities for patients with or at high risk for cardiovascular diseases, health equity and access to care remain significant areas of concern. This symposium will introduce learners to The Access to Health Care Initiative of the Association of Black Cardiologists (ABC) who will address these critical issues in a changing health care landscape by revealing disparities faced by minorities and high-risk patients and promulgating solutions to diminished access, especially to newer medications and therapies.
NOTE: This is a non-CME educational resource for US-based healthcare professionals, including physicians (MDs), nurse practitioners (NPs), physician assistants (PAs), nurses, pharmacists (ACPE), dieticians (CDR), and other allied health professionals.
Support:
Supported by educational grants from the Association of Black Cardiologists, Inc. and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.
Educational Objectives:
Upon completion of this activity, participants should be able to:
- Discuss the disproportionate burden of heart disease and stroke for high risk and minority patients and the mission of the ABC Access Initiative
- Summarize the barriers to access of quality care for high risk and minority patients, and the solutions proposed in the ABC Access Initiative to improve access, especially to newer therapies
- Identify evidence-based treatment recommendations to aggressively manage cardiovascular risk factors in high risk and minority patients, thereby reducing the incidence and consequence of CVD and stroke
Faculty Information:
Keith C. Ferdinand, MD, FACC, FAHA
- Professor of Medicine
- Tulane University School of Medicine
- Tulane Heart and Vascular Institute
- New Orleans, LA
Consultant/Independent Contractor: Quantum Genomics, Novartis, Amgen, Sanofi, Eli Lilly
Grants/Research Support: Boehringer Ingelheim
Cat Davis Ahmed, MBA
- Vice President, Policy and Outreach
- The FH Foundation
- Pasadena, CA
Disclosures: Mrs. Ahmed has nothing to disclose.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Hardware and Software Requirements:
This online activity must be viewed with the latest version of Chrome, Firefox or Internet Explorer. If you do not have these browsers, you can download Chrome here, Firefox here and Internet Explorer here. Optimal viewing requires a broadband connection of at least 3 Mbps and a 1 GHz processor with 1 GB RAM.